Symbol Surfing makes it fast & easy to find your next great idea. Just select a channel to get started.

Vertex Pharmaceuticals (NASDAQ: VRTX)

VRTX 187.49
1.48 (0.8%)

Open: 189.57 High: 192.55 Low: 187.20


External Links

52WL $187.20

The 52 Week Low is $187.20 set on Wed, Jun 16, 2021.

52WH $304.00

The 52 Week High is $304.00 set on Mon, Jul 20, 2020. The current price, $187.49, is 38% below the 52 Week High.

ATH $304.00

The All-Time High is $304.00 set on Mon, Jul 20, 2020. The current price, $187.49, is 38% below the All Time High.

52 Week Range

Jun 16, 2021
Jul 20, 2020

VRTX Earnings

Q4 Earnings for Oct, Nov & Dec

Mon, Feb 1, 2021

Since Q4 Earnings Report

VRTX 18.2%

Q1 Earnings for Jan, Feb & Mar

Thu, Apr 29, 2021

Since Q1 Earnings Report

VRTX 12.2%

VRTX Profile

Vertex Pharmaceuticals trades on the NASDAQ. VRTX's market cap is 50.4 Billion.

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex's pipeline includes gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease as well as small-molecule medicines targeting diseases associated with alpha-1 antitrypsin deficiency and APOL1-mediated kidney disease. Vertex also has an expanding research pipeline focused on inflammatory diseases, non-opioid treatments for pain, and genetic and cell therapies for type 1 diabetes and rare diseases.


Related Channels

YouTube Symbol Surfing

Watch these videos to learn how Symbol Surfing can increase your trading and investing knowledge and results.